VFA
LOXO

Virtus Fund Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

Virtus Fund Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$625K Buy
7,429
+5,152
+226% +$430K 0.01% 316
2017
Q3 		$210K Buy
+2,277
New +$177K ﹤0.01% 367

Other funds holding LOXO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Virtus Fund Advisers's LOXO Position: Q4 2017 in Review

Virtus Fund Advisers increased its Loxo Oncology, Inc (LOXO) stake by 226% in Q4 2017, buying an estimated $430K and bringing the position to 7,429 shares worth $625K. The position accounts for 0.01% of the portfolio, ranked #316.

Virtus Fund Advisers first reported a position in LOXO in Q3 2017 and has held it in 2 quarters since. 141 funds tracked by Wall St. Rank hold LOXO as of Q4 2017.

  • Virtus Fund Advisers held 7,429 shares of Loxo Oncology, Inc worth $625K as of Q4 2017.
  • Virtus Fund Advisers bought 5,152 Loxo Oncology, Inc shares in Q4 2017, an estimated $430K.
  • Loxo Oncology, Inc made up 0.01% of Virtus Fund Advisers's portfolio in Q4 2017, its #316 holding.
  • Virtus Fund Advisers first reported a position in Loxo Oncology, Inc in Q3 2017 and has held it in 2 quarters since.
  • 141 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q4 2017.

Based on Virtus Fund Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.